NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









InCephalo Therapeutics

InCephalo Therapeutics

Private
BaselHealthcare & Life Scienceshttps://www.incephalo.com/

Last Round

Grant

Aug 22, 2022

Total Funding Raised

$2.96M

Company Overview

InCephalo Therapeutics is a pharmaceuticals and biotechnology company that develops novel therapies for the treatment of brain cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

C-Lock technologyglioblastoma therapydrug delivery platformbrain cancer treatmentbiologic therapiesCNS drug deliverypreclinical biotechlocal drug administrationIL-12 therapyneuro-oncologycancer immunotherapycompartment-locked biologicssystemic toxicity reductionOrphan Drug Designationneurological diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InCephalo Therapeutics Comps

Public and private peers based on sector, stage, and business model.

InCephalo Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

InCephalo Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 22, 2022
AcceleratorJun 28, 2021
View all Funding Rounds

InCephalo Therapeutics Investors

Notable investors and investment history

InCephalo Therapeutics investors
InvestorRounds
EIT HealthGrant
Eurostars SME programmeGrant
Swiss State Secretariat for Education, Research and Innovation (SERI)Grant
BaseLaunchAccelerator
University of BaselGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors increased 1133% MoM, from 78 to 962.

  • Apr 1, 2025

    Monthly visitors grew 34% MoM.

View all signals

InCephalo Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InCephalo Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InCephalo Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range10
Year Founded2021
Last FundingAug 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.